Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1LZC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,511
Award facts
- Contract value 100% obligated
- $10,510.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,510.83 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pen injections on December 29, 2025, with a completion date of December 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical supply vehicle running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and established federal medical procurement vendor that supplies a broad portfolio of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company has demonstrated substantial capacity to fulfill federal procurement requirements through multiple competitively awarded contracts with the DLA Medical Supply Chain, ranging from small-value orders to substantial acquisitions exceeding $45,000. This delivery order for Zepbound, a diabetes medication, exemplifies AmerisourceBergen's role as a critical supplier of specialized pharmaceuticals across multiple therapeutic domains within the federal healthcare procurement landscape.
Quick answers
Who was awarded contract SPE2DR26F1LZC?
SPE2DR26F1LZC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F1LZC worth?
The government has obligated $10,511 on SPE2DR26F1LZC.
Is contract SPE2DR26F1LZC an order under another contract?
Yes. SPE2DR26F1LZC is a delivery order under SPE2DR25D2215, an indefinite delivery contract.
Was contract SPE2DR26F1LZC competed?
The extent of competition for SPE2DR26F1LZC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award